Status:
RECRUITING
Surgery As Needed for Oesophageal Cancer - 2
Lead Sponsor:
Bas P. L. Wijnhoven
Conditions:
Cancer of Esophagus
Eligibility:
All Genders
18+ years
Brief Summary
A prospective cohort study on active surveillance after neoadjuvant chemoradiation for oesophageal cancer: SANO-2 study.
Detailed Description
An active surveillance approach after completion of neoadjuvant chemoradiotherapy for locally advanced oesophageal cancer is being investigated in the SANO (Surgery As Needed for Oesophageal cancer) t...
Eligibility Criteria
Inclusion
- Operable patients who are planned to undergo or who recently underwent neoadjuvant chemoradiotherapy according to CROSS followed by surgical resection for histologically proven oesophageal squamous cell carcinoma or adenocarcinoma of the oesophagus or oesophago-gastric junction
- Age ≥18
- Written, voluntary, informed consent.
Exclusion
- Non-FDG-avid tumour at baseline PET-CT scan
- Initial treatment with endoscopic resection
- Patients who underwent of who are planned to undergo definitive chemoradiotherapy
- Language difficulty, dementia or altered mental status prohibiting the understanding and giving of informed consent.
Key Trial Info
Start Date :
March 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2029
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04886635
Start Date
March 9 2021
End Date
January 1 2029
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus University Medical Center
Rotterdam, South Holland, Netherlands, 3015 GD